ENDRA Life Sciences Inc. financial data

Symbol
NDRA on Nasdaq
Industry
Electromedical & Electrotherapeutic Apparatus
Location
3600 Green Court, Suite 350, Ann Arbor, MI
State of incorporation
DE
Fiscal year end
December 31
Former names
Endra Inc. (to 9/21/2016)
Latest financial report
10-Q - Q2 2024 - Aug 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 309 % -26.5%
Quick Ratio 192 % +29.4%
Debt-to-equity 26.8 % -10.9%
Return On Equity -162 % +4.22%
Return On Assets -128 % +1.73%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 72.4M shares +868%
Common Stock, Shares, Outstanding 72.4M shares +868%
Entity Public Float 10.3M USD
Common Stock, Value, Issued 7.24K USD +868%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 3.97M USD -36.8%
Selling and Marketing Expense 793K USD -32.6%
General and Administrative Expense 4.84M USD -7.06%
Operating Income (Loss) -9.6M USD +24.2%
Nonoperating Income (Expense) 1.7K USD -99.6%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -9.57M USD +21.8%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -9.57M USD +21.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 4.82M USD
Inventory, Net 2.71M USD -1.66%
Assets, Current 6.71M USD -17%
Property, Plant and Equipment, Net 91.8K USD -52.4%
Operating Lease, Right-of-Use Asset 272K USD -36.9%
Other Assets, Noncurrent 5.99K USD 0%
Assets 10.4M USD +13%
Accounts Payable, Current 300K USD -27.6%
Employee-related Liabilities, Current 326K USD +61.2%
Liabilities, Current 1.35M USD -33.6%
Operating Lease, Liability, Noncurrent 98.4K USD -65%
Liabilities 1.45M USD -37.4%
Retained Earnings (Accumulated Deficit) -96.9M USD -10.9%
Stockholders' Equity Attributable to Parent 8.99M USD +29.8%
Liabilities and Equity 10.4M USD +13%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.14M USD +14.5%
Net Cash Provided by (Used in) Financing Activities 469K USD
Net Cash Provided by (Used in) Investing Activities -23.8K USD +11.9%
Common Stock, Shares Authorized 1B shares +1150%
Common Stock, Shares, Issued 72.4M shares +868%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -2.53M USD -8.55%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 6.4M USD +32.8%
Interest Paid, Excluding Capitalized Interest, Operating Activities 8.8K USD
Deferred Tax Assets, Valuation Allowance 21.2M USD +14.2%
Deferred Tax Assets, Gross 16.9M USD +22.5%
Operating Lease, Liability 281K USD -36.7%
Depreciation 105K USD -6.8%
Payments to Acquire Property, Plant, and Equipment 27K USD 0%
Lessee, Operating Lease, Liability, to be Paid 304K USD -39.6%
Property, Plant and Equipment, Gross 580K USD -12%
Operating Lease, Liability, Current 183K USD +12.1%
Lessee, Operating Lease, Liability, to be Paid, Year Two 203K USD +3%
Lessee, Operating Lease, Liability, to be Paid, Year One 101K USD +3%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 22.8K USD -61.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 203K USD 0%
Deferred Tax Assets, Operating Loss Carryforwards 1.04M USD +54.7%
Preferred Stock, Shares Authorized 10M shares
Additional Paid in Capital 106M USD +12.3%
Depreciation, Depletion and Amortization 34.5K USD +81.3%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Operating Leases, Future Minimum Payments Due 406K USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares